About the Product
Includes 1 hour and 5 minute Windows Media Video File and PowerPoint presentations for immediate download.
Under the final rule of the Sunshine Act, life science manufacturers are required to report on a wide variety of payments made directly or indirectly to physicians and teaching hospitals, with some exceptions. One exception included payments made indirectly to physicians for speaking at accredited continuing medical education (CME) programs. In a surprising reversal of policy, CMS recently removed that exception as part of a host of revisions to the Sunshine requirements. The agency’s statements accompanying the exception’s removal, however, have created confusion as to what will be the practical impact of the change.
- Analysis of the removal of the CME exception, CMS’s related guidance, and the practical implications
- Trends in CME and physician involvement
- Comparison of key stakeholder perspectives
Speaker:
Brian A. Bohnenkamp
Senior Associate
King & Spalding LLP
Participants that will find this webinar most beneficial will be those involved in medical device, pharmaceutical, biotechnology, and diagnostic companies. Job titles of attendees that will be most applicable for this session will be:
- Medical Communications
- Regulatory Affairs
- Legal Counsel
Contact:
Brooke Akins | Manager, Market Intelligence | 312.224.1693 webinars@q1productions.com
CONTACT US
Q1 Productions
500 N. Dearborn Suite 500 | Chicago, IL 60654
Chicago, IL 60654
T: 312.822.8100
F: 312.873.3969
marketing@q1productions.com
PRODUCTS
All Events
Conferences
Webinars
Forums